- |||||||||| albendazole / Generic mfg.
Enrollment closed, Trial primary completion date: Efficacy and Safety of IVM/ALB Co-administration (clinicaltrials.gov) - Dec 14, 2020 P2/3, N=1673, Active, not recruiting, Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2020 --> Feb 2020
- |||||||||| ivermectin / Generic mfg.
Ivermectin! (Twitter) - Dec 13, 2020
|